Asian Medtech Associations Reg Networking: ASEANMed Drives Medtech Agenda Forward Despite COVID-19 – Part Two

The Asian Medtech Associations Regulatory Networking discussions this month centered on strategies to control COVID-19 locally and the activities of the ASEANMed industry association. This editorial feature is hosted by Medtech Insight, along with the ARQon Asia Regulatory and Quality Consultancy and the Asia Regulatory Professional Association. This is the second of two articles on the discussions.

AEC

The effects of COVID-19 have been all-encompassing, even in countries where control strategies put in place early in the pandemic have paid off.

Asian countries have generally fared relatively well in terms of restricting the advance of SARS-CoV-2, but the travel restrictions and social distancing rules put in place have not been without impact on regional regulatory routines as well as wider economic activity life, as alluded to in the first article on the latest regulatory networking discussions

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Asia

More from Geography